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Abstract
Background
The use of filter paper as a simple, inexpensive tool for storage and transportation of blood,
‘Dried Blood Spots’ or Guthrie cards, for diagnostic assays is well-established. In contrast,
there are a paucity of diagnostic evaluations of dried cerebrospinal fluid (CSF) spots. These
have potential applications in low-resource settings, such as Laos, where laboratory facili-
ties for central nervous system (CNS) diagnostics are only available in Vientiane. In Laos, a
major cause of CNS infection is Japanese encephalitis virus (JEV). We aimed to develop a
dried CSF spot protocol and to evaluate its diagnostic performance using the World Health
Organisation recommended anti-JEV IgM antibody capture enzyme-linked immunosorbent
assay (JEV MAC-ELISA).
Methodology and Principal Findings
Sample volumes, spotting techniques and filter paper type were evaluated using a CSF-
substitute of anti-JEV IgM positive serum diluted in Phosphate Buffer Solution (PBS) to
end-limits of detection by JEV MAC-ELISA. A conventional protocol, involving eluting one
paper punch in 200μl PBS, did not detect the end-dilution, nor did multiple punches utilising
diverse spotting techniques. However, pre-cut filter paper enabled saturation with five times
the volume of CSF-substitute, sufficiently improving sensitivity to detect the end-dilution.
The diagnostic accuracy of this optimised protocol was compared with routine, neat CSF in
a pilot, retrospective study of JEV MAC-ELISA on consecutive CSF samples, collected
2009–15, from three Lao hospitals. In comparison to neat CSF, 132 CSF samples stored as
dried CSF spots for one month at 25–30°C showed 81.6% (65.7–92.3 95%CI) positive
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agreement, 96.8% (91.0–99.3 95%CI) negative agreement, with a kappa coefficient of 0.81
(0.70–0.92 95%CI).
Conclusions/Significance
The novel design of pre-cut filter paper saturated with CSF could provide a useful tool for
JEV diagnostics in settings with limited laboratory access. It has the potential to improve
national JEV surveillance and inform vaccination policies. The saturation of filter paper has
potential use in the wider context of pathogen detection, including dried spots for detecting
other analytes in CSF, and other body fluids.
Author Summary
Japanese encephalitis virus infection is widespread in Asia, and primarily affects children
in poor, rural areas. The virus spreads to the brain and spinal cord resulting in significant
death and disability. Diagnosis requires testing for the immune response ‘antibody’ spe-
cific to Japanese encephalitis virus in the cerebrospinal fluid that surrounds the brain and
spinal cord. However, in most areas where the infection occurs there are no laboratory
facilities. In the absence of laboratory diagnosis, we have poor knowledge of the extent of
the problem in these areas. Dried blood spots on filter paper have been used widely for
many years as simple, cost-effective tools for transporting samples for testing. However,
there have been few attempts at using dried cerebrospinal fluid spots. We developed a
technique for using dried spots to store and test cerebrospinal fluid for antibodies to Japa-
nese encephalitis virus. We compared the results of dried spots with routine neat cerebro-
spinal fluid in 132 patient samples, and demonstrated excellent agreement between the
two tests. This novel method for saturating dried cerebrospinal fluid spots has the poten-
tial to enhance our knowledge of Japanese encephalitis virus epidemiology, and inform
health policies where they are most needed. It could also be transferred for use in diagnos-
ing other infectious diseases, including using other body fluid samples.
Introduction
The last few decades have seen a substantial growth of novel and complex diagnostic tests [1].
This has not been accompanied by the same development in global laboratory infrastructure, a
fundamental component of any effective healthcare system [2]–[4]. In settings with poor access
to laboratories, the use of dried blood spots on filter paper (DBS) is now a well-established
diagnostic tool for storing and transporting blood [5]–[9]. DBS obviates the need for a cold
chain. The technique is also simple, economical and requires smaller sample volumes.
Strikingly, there is a paucity of data on use of dried spots of other body fluids [5]. There are
only three publications evaluating the use of dried cerebrospinal fluid (CSF) spots (DCS) in
diagnosing infectious diseases [10]–[12]. This may in part be due to the significant level of
technical expertise required to perform a lumbar puncture (LP). CSF is more difficult to obtain,
available in smaller volumes, often with lower concentrations of analyte, and may have lower
sensitivity of corresponding diagnostic assays than for blood. Furthermore, approvals and
practicalities of studies involving LPs are more challenging. It has been acknowledged that
research involving CNS infections has been a neglected field [13]. However, it is also possible
that more DCS methods have been tried, proved futile and were not published.
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Amongst CNS infections, Japanese encephalitis virus (JEV) is recognised as the most com-
mon causative pathogen in Asia. In the 24 endemic countries it is suggested that JEV causes
67,900 cases, and 20,000 deaths per year [14], [15]. In the Lao PDR (Laos), there is evidence to
suggest that JEV is a major cause of CNS infection [16], [17]. However, the wider epidemiology
of JEV outside Vientiane is poorly documented due to the lack of laboratory facilities in the
provinces. The diagnosis of JEV relies on laboratory facilities to test for anti-JEV IgM in the
blood and/or CSF, with significantly increased proportion of false positive results if relying on
blood alone [17]. Improved JEV laboratory networks and infrastructure have developed since
2008, with a global central laboratory in Japan, regional centres for the Western Pacific in
China and Korea and respective national centres [18], [19]. The central laboratory performs
the reference standard test, plaque reduction neutralisation assay (PRNT)[18]–[22]. However
the mainstay of routine diagnosis involves commercial kits performing anti-JEV IgM antibody
capture enzyme-linked immunosorbent assay (JEV MAC-ELISA).
The use of DCS in the diagnosis of JEV by JEV MAC-ELISA would have potential applica-
tion in low-resource settings, for diagnostics, wider epidemiological studies on the aetiology of
CNS infections and impact of vaccination. We aimed to optimise a DCS protocol for the detec-
tion of anti-JEV IgM using JEV MAC-ELISA and evaluate its performance in a pilot study of
consecutive patient samples as compared to routine neat CSF.
Methods
Patient samples
Patient CSF and serum samples were collected at three hospitals in Vientiane, the Friendship,
Children and Setthathirat Hospitals, from 2009 to 2015 (Fig 1). CSF was collected by LP from
patients with suspected CNS infection, and without contraindications to LP, according to the
judgment of the responsible physician. Written consent was obtained from the patient, parent
and/or guardian. Samples were sent to Mahosot Hospital and stored at -80°C.
Ethical considerations
The study was part of a study on the causes of CNS infections in Laos. Ethical clearance was
granted by the Ethical Review Committee of the Faculty of Medical Sciences, National Univer-
sity of Lao, and the Oxford University Tropical Ethics Research Committee, Oxford, UK. Diag-
nostic testing was performed on anonymised and frozen CSF samples. LPs were performed as
part of a routine diagnostic service if verbal (2003–2006) or written (2006–2011) consent was
given by patients or their parents/guardian. Consent for all patients was documented on a form
that had been approved by the ethics committee. The lead investigator has been trained in
Good Clinical Practice, and has completed Human Tissues Training.
Anti-JEV IgM ELISA (JEV MAC-ELISA)
TheWHO recommended commercial JEV MAC-ELISA assay is the Inbios JE Detect (Wash-
ington, USA) [19]. This measures the Optical Density (OD) of each sample with JEV Recombi-
nant Antigen, JERA, compared to Normal Control Antigen (NCA) to adjust for background
nonspecific reactivity. 100μl of diluted sample (1/10 dilution for CSF as recommended by
WHO) are used for a single test, 50μl in the JERA well and 50μl in the NCA well. The result is
an Immune Status Ratio, ISR, (JERA OD/ NCA OD) with qualitative interpretation, according
to manufacturer’s instructions, as positive if>6.0, equivocal if 4.0–6.0, or negative if<4.0.
Equivocal results were classed as negative as per standard protocol in research optimising diag-
nostic tests [23], [24].
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Filter paper
Two types of filter paper were chosen, and utilised in all experiments. The 903 Protein Saver
Card (903) (Whatman, GE Healthcare Life Sciences, UK) has been used as DBS for neonatal
screening since 1963 [8]. It is made of highly purified cellulose cotton paper and is one of two
FDA approved cards for DBS [5]. They have been used in the diagnosis of multiple diseases,
involving elution and corresponding ELISA or PCR, including the detection of specific anti-
bodies in CSF [25]. The 3MM Chr Blotting paper (3MM) (Whatman, GE Healthcare Life Sci-
ences, UK) is available as large sheets, is less expensive and more suitable for broader
application in a resource limited setting. Despite being produced as a blotting paper rather
than a collection paper, 3MM has been used reliably in serology testing of DBS [26], [27].
Optimisation experiments
CSF-substitute. CSF-substitutes were prepared to compare the end-limit of detection of
the DCS method to the routine method from neat sample, and because of the limited CSF
Fig 1. Study sites: Geographical distribution of four hospitals involved in patient recruitment, in Vientiane (colour map), and with respect to the
Lao PDR (grey map).
doi:10.1371/journal.pntd.0004516.g001
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volumes available. A fluid was needed with similar consistency to CSF, and low IgM titre. Two
anti-JEV IgM positive serum samples (A and B respectively) were diluted in PBS to the limit of
detection-the highest dilution found positive by JEV MAC-ELISA. This is referred to here as
the end-limit dilution, and was 1:1600 and 1:3200 for samples A and B, respectively. It was
expected that there would be some loss in sensitivity when testing from dried spots so two addi-
tional dilutions, more concentrated, were also prepared: x2 (1:800 and 1:1600 for A and B
respectively) and x4 end-limit dilutions (1:400 and 1:800 for A and B respectively). All the
CSF-substitutes, three dilutions (end-limit, x2 end-limit and x4 end-limit) from the two sera A
and B, were used in subsequent experiments. When directly used for ELISA testing, not spotted
on paper, it is referred as neat CSF-substitute.
DCS preparation and elution. The DCS protocol was adjusted to compare sample vol-
umes, spotting techniques and filter paper. The general protocol is described here, with the var-
iables elaborated below. The CSF-substitutes were spotted on 3MM and 903 filter paper, with
the centre of the spot marked as an indent with a pin. These were air-dried for 4 hours and
stored in individual zip-lock plastic bags with a teaspoon of silica granules and then stored
overnight in an air-conditioned laboratory at 25–30°C. The elution process involved inserting
punched or pre-cut filter paper in 1.5ml Eppendorf tubes, adding different volumes of PBS/
0.05% Tween-20, agitating on a shaker for 1 hour at 180 revs/minute at room temperature, and
refrigerating overnight at 4°C. The tubes were then centrifuged for 10mins at 3,000g at 20°C
and 100μl undiluted supernatant was used to perform JEV MAC-ELISA, using the JEV Detect
InBios kit. Neat CSF-substitute was tested, diluted 1/10, on the same plate as per the manufac-
turer’s instructions. Each plate was validated with kit controls, as well as a PBS spotted on filter
paper as an additional negative control.
A conventional DBS protocol was initially utilised, as per the in-house protocol for DBS and
studies involving a wide-variety of analytes using DBS [7], [9]. 100μl of CSF-substitute was
spotted on filter paper, and eluted as an 8mm punch (skin-puncher, Stiefel, Maidenhead, UK)
in 200μl of PBS/0.05% Tween-20. Decontamination of the puncher was performed by punch-
ing filter paper soaked in Virchon 1%, and then three times in filter paper soaked in sterile
water.
A modified protocol was used to increase the volume of CSF-substitute eluted using eight
and ten 6mm punches in the minimum volume of PBS/0.05% Tween-20, 325μl, to provide the
275μl required eluate for subsequent JEV MAC-ELISA and potentially additional anti-dengue
IgM and dengue NS1 assays. Different sample volumes were evaluated using the modified pro-
tocol with ten 6mm punches: 1) a single 100μl spot as previously described, 2) respotting a
100μl spot after completely air-drying a single spot, and 3) Two separate spots, with the inner-
most 5 punches taken from each spot.
A pre-cut circle protocol was performed completely saturating a pre-cut filter paper circle.
Increasing volumes of PBS were spotted on pre-cut filter paper placed on a 3x3cm clear plastic
square. The largest volume of PBS the circle could hold without the fluid seeping off was
defined as the saturating volume. This was 250μl spotted on a 1.49cm diameter circle, five
times the volume of CSF-substitute per surface area when spotted on a large area of paper. This
entire circle was eluted in 200μl PBS/0.05%Tween-20.
Testing strategy. The two patient samples at each of three dilutions of CSF-substitutes
were subjected to the various protocols. Experiments were performed as duplicates tested on
the same JEVMAC-ELISA plate, and the entire protocol was repeated on another day. In total
there were 4 to 6 replicates of each experiment. The JEVMAC-ELISA result is a binary categor-
ical outcome ‘positive’ and ‘negative’, and results of experiments are summarised as percentage
of replicates (4–6) positive for each sample and as a total (62–65).
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Evaluation of the optimised protocol using patient samples
Retrospective, consecutive analysis was performed on available CSF from all patients tested for
JEV between February 2009 and July 2015. CSF was spotted on 903 paper as per the optimised
‘pre-cut circle’ protocol detailed above, and stored at 25–30°C for 30 days as an approximation
of the maximum time for the paper to reach the laboratory if this was performed in the field.
DCS and neat CSF were compared on the same plate. Investigators were blinded to the previ-
ous neat CSF JEV ELISA results.
Statistics
The sample size (n = 86) was calculated with values for sensitivity of Inbios JEV MAC-E-
LISA = 53%, expected positive agreement DCS with neat CSF = 75%, and expected negative
agreement = 98%, programming formulae (as per the CDC report referenced by T. Lee) based
on estimation of a kappa coefficient, into Microsoft Excel [23], [28]. Results are presented in
2x2 tables, analysed by reporting ‘positive percentage agreement’ = (positive by both DCS and
neat CSF)/(positive by neat CSF), ‘negative percentage agreement’ = (negative by both DCS
and neat CSF)/(negative by neat CSF), overall percentage agreement (positive or negative
agreement by both DCS and neat CSF) and kappa coefficient with respective 95% confidence
intervals calculated in STATA 13.1 (College Station, Tx) [29]. The analysis acknowledges the
fact that the comparison was not made with the reference standard, PRNT, that is only per-
formed in a few reference laboratories. Further, the samples tested were paired, being taken
from the same patient sample.
Results
Optimisation experiments
The conventional DBS protocol applied to DCS did not produce any positive results at the
end-limit dilutions (Table 1A displays results for 903, for 3MM see S1 Table). The modified
protocol with increased number of punches of the eluent, also did not produce any positive
results at the end-limit dilutions (Table 1B and S1 Table). Experiments were performed using
CSF-substitute at x2 and x4 end-limit dilutions, to identify the limit of detection of the modi-
fied protocol. At the lowest dilution, x4 end-limit dilution, 25% of replicates were positive
using a single spot. The same dilution was used with a respotting technique and produced 75%
positive replicates. A third technique using the same dilution spotted as two spots, with half the
punches taken from the centre of each spot, was positive in 58% and 25% % of replicates, for
903 and 3MM, respectively. The only difference between the filter paper types was more fre-
quent detection (58 vs 25%) using two spots on 903 versus 3MM.
The final protocol evaluated a pre-cut circle of filter paper saturated with the maximal vol-
ume of CSF. A 1.49cm diameter pre-cut circle could be loaded with 250μl CSF-substitute, and
this permitted detection of anti-JEV IgM in 100% of replicates (Table 1C and S1 Table). In
comparison, spotting 100μl on to a filter paper filled an approximate 2.1cm diameter circle for
CSF and 1.3cm diameter sheet for blood [30]. Limitations of serum volume and JEVMAC-E-
LISA precluded testing all protocols at x2 and x4 end-limit dilutions. The pre-cut circle proto-
col with 903 filter paper was ultimately performed with 903 rather than 3MM filter paper in
the optimised protocol as it showed marginally better results and was easier to handle.
Evaluation utilising the optimised protocol
CSF was received and tested for JEV using Inbios JEV MAC-ELISA from 248 patients admitted
from February 2009 to July 2015. 132 patients had sufficient frozen CSF volumes, 10μl for neat
Dried CSF Spots for Diagnosing Japanese Encephalitis Virus
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004516 March 17, 2016 6 / 12
CSF ELISA testing and 250μl to make the dried CSF spot following pre-cut circle protocol.
After 30 days at room temperature (25–30°C) the DCS and corresponding neat CSF were tested
by Inbios JEV MAC-ELISA. The positive agreement for dried CSF spots compared to neat CSF
was 81.6% (65.7–92.3 95%CI), negative agreement 96.8% (91.0–99.3 95%CI), overall agreement
92.4% and kappa coefficient 0.81 (0.70–0.92 95%CI), Table 2. Thirty-eight neat CSF samples
(29%) and 34 filter paper samples (26%) tested positive for JEV.
Discussion
There are still considerable global deficits in laboratory capacity for diagnosing CNS infections
[2], [3]. This is seen in Laos, where laboratory diagnosis of JEV is confined to the capital, Vien-
tiane, and elsewhere in rural Asia. DCS has the potential to provide a simple tool for improving
clinical diagnostics and our understanding of the epidemiology of CNS infections. This study
Table 2. Anti-JEV IgM ELISA (JEV MAC-ELISA) results of consecutive patient samples comparing
Dried Cerebrospinal Fluid Spots (DCS) on filter paper using the pre-cut protocol vs routine neat Cere-
brospinal Fluid.
Neat CSF
Positive Negative Total
Filter paper
Positive 31 3 34
Negative 7 91 98
Total 38 94 132
doi:10.1371/journal.pntd.0004516.t002
Table 1. JEV MAC-ELISA results from DCS using CSF-substitutes, 903 filter paper and various protocols for sample spotting.
Number of samples positive (%) by Inbios JE Detect
Total (SA+ SB), CSF-substitute A (SA) and CSF-substitute B (SB) at three dilutions
Filter
paper
Sample
spotting
Punches/
Cutting
x4 End-limit dilution x2 End-limit dilution End-limit dilution
A) Conventional DBS Protocol Total
(n = 8)
SA
(n = 4)
SB
(n = 4)
903 Single 100μl 1 (8mm) 0 (0%) 0 (0%) 0 (0%)
B) Modiﬁed Protocol Total
(n = 12)
SA
(n = 6)
SB
(n = 6)
Total
(n = 12)
SA
(n = 6)
SB
(n = 6)
Total
(n = 12)
SA
(n = 6)
SB
(n = 6)
903 Single 100μl 10 (6mm) 3 (25%) 2 (33%) 1 (17%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
903 Respot 100μl 10 (6mm) 9 (75%) 6
(100%)
3 (50%) 2 (17%) 2 (33%) 0 0 (0%) 0 (0%) 0 (0%)
903 Two 100μl 10 (6mm) 7 (58%) 6
(100%)
1 (17%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
C) Pre-cut circle Protocol Total
(n = 8)
SA
(n = 4)
SB
(n = 4)
903 Single 250μl 14.9mm 8 (100%) 4
(100%)
4
(100%)
DCS: Dried CSF Spot; DBS: Dried Blood Spot; Inbios JE Detect: WHO recommended commercial JEV MAC-ELISA for Anti-JEV IgM detection. CSF-
substitutes SA and SB refer to the sera A and B that were used for their preparation. Modiﬁed Protocol: 3 sample volume techniques (Single/Respot/
Double), 2 types of ﬁlter paper, 3MM/903, and 2 types of punches. End-limit dilution: highest dilution of serum found positive by Inbios JE detect,
corresponding to the limit of detection of the kit when tested from neat CSF-substitute. For SA: End-limit dilution = 1/1600, x2 End-limit dilution = 1/800, x4
End-limit dilution = 1/400. For SB: End-limit dilution = 1/3200, x2 End-limit dilution = 1/1600, x4 End-limit dilution = 1/800.
doi:10.1371/journal.pntd.0004516.t001
Dried CSF Spots for Diagnosing Japanese Encephalitis Virus
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004516 March 17, 2016 7 / 12
developed a robust protocol using DCS for the diagnosis of JEV by JEV MAC-ELISA, with
excellent agreement demonstrated in a pilot study of patient samples.
The use of DBS for storing, transporting and detecting anti-JEV IgM and anti-dengue IgM
have already been well-documented in previous studies, and this was not repeated here. [21],
[31]–[34]
The experiments performed to optimise the DCS protocol highlighted the key difference
between blood and CSF, with poor performance of the conventional DBS and modified proto-
cols likely due to low IgM concentration in the final eluate, IgM concentrations are lower in
CSF than in blood [35]. This was corroborated by the improved sensitivity seen by increasing
the serum concentration in the modified DCS protocol to x4 end-limit dilution of the neat
CSF-substitute. This problem is compounded by the lower viscosity of CSF, leading to a wider
distribution on filter paper [30]. There was no evidence to suggest a difference in the perfor-
mance of the two types of filter paper, 903 and 3MM. Respotting, aiming to increase the analyte
concentration, did not improve sensitivity. There is literature to suggest that analyte concen-
trates in the centre of a DBS [36]–[38]. However taking half (4 or 5) the punches from the cen-
tre of two spots did not demonstrate higher sensitivity.
In contrast, the ‘pre-cut circle’ protocol worked very well. Saturation of filter paper could be
achieved by cutting beforehand and then carefully loading with the maximum CSF volume the
paper could hold. The volume of CSF that could be added to the pre-cut circle was five times
that of a single CSF sample spotted on a sheet of filter paper. Prior cutting has been utilised in
DBS [39], [40]. However, while the term ‘saturation’ is frequently used in dried spot protocols,
this is not true saturation, by which we mean loading of fluid to the maximal amount that the
filter paper will possibly absorb before it leaks off the filter paper. The use of this saturation
technique has important implications in DBS in diagnostics for diseases that have low concen-
trations of analyte, dried spots involving other body fluids, as well as other fields of research.
Advantages of the pre-cut circle protocol include greater sampling efficiency, as it prevents loss
of the analyte not punched from the filter paper. It is simpler, quicker, more reliable and
reduces concerns regarding cross-contamination.
The retrospective study of 132 consecutive patients recruited from three hospitals demon-
strated a high level of agreement between the optimised ‘pre-cut’ circle protocol and neat CSF,
with positive agreement of 81.6% (65.7–92.3 95%CI), negative agreement of 96.8% (91.0–99.3
95%CI) and kappa coefficient 0.81 (0.70–0.92 95%CI). It is possible that kappa agreement over-
estimates the effect size, as the comparison involved paired samples, tested using the same diag-
nostic assay. Further, kappa agreement has been criticised as being dependent on disease
prevalence, with a low prevalence seen in this study risking a false negative result [41]. How-
ever, it is the industry standard [28], [29], [42]. P values for the kappa statistic are not presented
as these are considered misleading [42]–[44].
10 of 132 (8%) CSF samples had discordant ELISA results between neat CSF and pre-cut
saturated paper samples. Refreezing samples may have affected results. Unfortunately there
was insufficient sample volumes to investigate this by the reference standard, PRNT.
Cross-reactivity with JEV MAC-ELISA occurs with other Flavivirus antibodies, and in this
region, testing for dengue is crucial. We had insufficient sample volumes to test for dengue
antibodies as well as JEV antibodies in the DCS. A larger study is needed to evaluate the differ-
ential diagnosis of JEV from other flaviruses, performing the protocol in ‘full’ with 500μl CSF,
on a 2.1cm diameter circle, eluting with 400μl PBS/0.05% Tween-20.
Rules of thumb for the evaluation of any diagnostic test are the ‘ASSURED’ criteria, i.e.
whether it is Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free
and Deliverable to end-users [45]. The currently used WHO recommended standard test for
JEV is the commercial Inbios JEV MAC-ELISA, CSF usually diluted 1:10 with a sensitivity
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under field conditions suggested to be 53% [23]. However, it is not accessible for the large pop-
ulations at risk of JEV living in rural Asia. The DCS ‘pre-cut and saturated’ protocol potentially
provides a simple, economical and accessible tool to store and transport CSF. The requirements
for the technique are minimal, as PBS/ 0.05% Tween-20 and filter paper are easily available and
inexpensive. Further work is crucial to evaluate the technique in larger cohorts, preparing dried
CSF spots in multiple centres under field conditions, transporting the spots at the high ambient
temperatures experienced in Asia, storing for longer periods (months to years), and testing
paired with neat CSF. Ideally this could be performed as a diagnostic accuracy study, compar-
ing both serum and CSF anti-JEV IgM ELISA results with PRNT, and with testing for anti-den-
gue IgM and Dengue NS1 antigen by JEV MAC-ELISA. It is notable that DCS may improve
access to diagnostics in areas with poor laboratory facilities but does not reduce the time for
diagnostic processing or ‘turnaround time’, and this is still a pertinent gap in this field. Permit-
ting the collection, storage, and shipment of samples without the need for cold chain, this pro-
tocol could undoubtedly aid JEV surveillance by collecting data from rural hospitals with staff
able to perform LPs that were not accessible before.
This novel design has significant implications for use in the wider context of pathogen
detection, including dried spots methods for other analytes in CSF, and other body fluids.
There are no facilities for systematic, population based surveillance of CNS infections in Laos
outside the capital, as is the case in many parts of the world [46]. Even in countries where sur-
veillance is performed, there are deficits in laboratory capacity, for diagnostics of JEV and
other similar pathogens [3], [17], [23]. This affects both clinical management, outcome and
epidemiological understanding. This is illustrated by the current epidemic of Zika virus, a
related Flavivirus, with an unclear and poorly characterised association with neurological com-
plications. There is an urgent need for simple and economical solutions to improve our under-
standing of the aetiology and wider epidemiology of CNS infections. With the introduction of
nationwide JEV vaccination, it is likely that diagnosis by CSF will be even more important, and
dried CSF spots could help understand the impact of vaccination.
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